A. Kreuter

Characterization of Vascular Niche in Systemic Sclerosis by Spatial Proteomics.

Yi-Nan Li, A. Matei, A. Györfi, 2024, Circulation research.

The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase‐1 antibodies

M. Worm, G. Riemekasten, T. Krieg, 2016, The British journal of dermatology.

S2k guideline: Diagnosis and therapy of localized scleroderma

Jörg Wenzel, N. Hunzelmann, R. N. Werner, 2024, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes

R. Knobler, M. Olszewska, J. Seneschal, 2024, Journal of the European Academy of Dermatology and Venereology.

Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients

Manfred, Matthias Schneider, S. Karrer, 2017 .

Merkel Cell Polyomavirus DNA in Persons without Merkel Cell Carcinoma

H. Pfister, T. Krieg, C. Mauch, 2009, Emerging infectious diseases.